Creo Historical Income Statement
| CREO Stock | 16.00 0.13 0.81% |
Historical analysis of Creo Medical income statement accounts such as Interest Expense of 420 K, Selling General Administrative of 42.5 M or Total Revenue of 32.3 M can show how well Creo Medical Group performed in making a profits. Evaluating Creo Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Creo Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Creo Medical Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Creo Medical Group is a good buy for the upcoming year.
Creo |
About Creo Income Statement Analysis
Creo Medical Group Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Creo Medical shareholders. The income statement also shows Creo investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Creo Medical Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Creo Medical Group. It is also known as Creo Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Creo Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Creo Medical Group current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creo Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Creo Medical's Cost Of Revenue is comparatively stable compared to the past year. Interest Income is likely to gain to about 735 K in 2024, despite the fact that EBIT is likely to grow to (22.9 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 237K | 248K | 400K | 420K | Depreciation And Amortization | 2.6M | 3.1M | 3.4M | 3.6M |
Creo Medical income statement Correlations
Click cells to compare fundamentals
Creo Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Creo Medical income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 641.7K | 1.6M | 2.6M | 3.1M | 3.4M | 3.6M | |
| Interest Expense | 14.1K | 97K | 237K | 248K | 400K | 420K | |
| Selling General Administrative | 19.0M | 27.6M | 41.5M | 43.9M | 40.5M | 42.5M | |
| Gross Profit | (636.8K) | 2.4M | 9.0M | 10.0M | 15.3M | 16.1M | |
| Other Operating Expenses | 19.0M | 32.8M | 55.1M | 58.0M | 55.6M | 58.4M | |
| Operating Income | (19.0M) | (23.4M) | (30.0M) | (30.8M) | (24.8M) | (23.6M) | |
| Ebit | (18.6M) | (23.4M) | (30.1M) | (30.7M) | (24.1M) | (22.9M) | |
| Ebitda | (18.0M) | (21.8M) | (27.5M) | (27.6M) | (20.7M) | (21.7M) | |
| Total Operating Expenses | 18.4M | 25.8M | 39.0M | 40.8M | 40.1M | 42.1M | |
| Income Before Tax | (18.6M) | (23.5M) | (30.3M) | (31.0M) | (24.5M) | (23.3M) | |
| Total Other Income Expense Net | 260.0K | (70K) | (380K) | (200K) | 300K | 315K | |
| Net Income | (15.9M) | (20.3M) | (24.6M) | (26.9M) | (21.7M) | (20.6M) | |
| Income Tax Expense | (2.7M) | (3.1M) | (5.7M) | (4.0M) | (2.8M) | (2.9M) | |
| Net Income From Continuing Ops | (15.9M) | (20.3M) | (24.6M) | (26.9M) | (21.7M) | (20.6M) | |
| Cost Of Revenue | 650.2K | 7.0M | 16.1M | 17.2M | 15.5M | 16.3M | |
| Net Income Applicable To Common Shares | (9.9M) | (15.9M) | (20.3M) | (24.6M) | (22.1M) | (21.0M) | |
| Research Development | 8.1M | 10.2M | 12.9M | 13.5M | 11.9M | 9.3M | |
| Tax Provision | (2.7M) | (3.1M) | (5.7M) | (4.0M) | (2.8M) | (2.9M) | |
| Interest Income | 311.3K | 178.1K | 31K | 66K | 700K | 735K | |
| Selling And Marketing Expenses | 8.8M | 11.9M | 15.4M | 16.6M | 15.2M | 13.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.